Valeria Kogan, PhD, Founder and CEO of Fermata has been recognized as one of Forbes' “30 Under 30” in 2022, Valeria is a serial entrepreneur with a proven track record in biotechnology and innovation.

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ...

President Trump has inherited an evolving chemical and biological threat landscape, but not one he hasn’t encountered before.

India needs to grow at 8 percent for up to two decades to become a developed nation by 2047, the Economic Survey said on ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ...

India needs to grow at 8 per cent for up to two decades to become a developed nation by 2047, the Economic Survey said on Friday, pitching for a slew of reforms, including land and labour, to achieve ...

Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, capable of binding and destroying previously undruggable disease-causing ...

A graduate of Stanford University's prestigious EENT Innovation Biodesign program in 2019, Diag-Nose.io is redefining ...

Businesses in the East of England received more than £480m in venture capital investment during the final quarter of last year – a 61pc ...

There are no better proving grounds than the streets of New York City. It’s where dreams meet steel and concrete, where ...

As the Doomsday Clock ticks dangerously close to midnight, humanity faces escalating nuclear threats, climate disasters, and ...